C = Program Chair | F = Faculty | S = Session Chair
![]() Inhye Ahn, MD Dana-Farber Cancer Institute Boston, Massachusetts, United States |
![]() Paolo Ghia, MD, PhD Università Vita-Salute San Raffaele Milano, Italy |
![]() Andrew Roberts, MBBS, PhD, FRACP FRCPA Peter MacCallum Cancer Centre and Royal Melbourne Hospital Melbourne, Australia |
|
![]() Michael Gillette, MD, PhD Broad Institute of MIT and Harvard Cambridge, Massachusetts United States |
![]() Lindsey Roeker, MD Memorial Sloan Kettering Cancer Center New York, New York United States |
![]() ![]() Jennifer Brown, MD, PhD Dana-Farber Cancer Institute Boston, Massachusetts United States |
![]() John Gribben, MD, DSc Barts Cancer Institute London, United Kingdom |
|
![]() Jan A. Burger, MD, PhD The University of Texas MD Anderson Cancer Center Houston, Texas United States |
![]() Romain Guièze, MD Université Clermont Auvergne Clermont-Ferrand, France |
![]() Richard Rosenquist, MD, PhD Karolinska Institutet Stockholm, Sweden |
![]() John Burke, MD Rocky Mountain Cancer Centers Aurora, Colorado United States |
![]() ![]() Michael Hallek, MD, PhD University of Cologne Cologne, Germany |
![]() Davide Rossi, MD, PhD Oncology Institute of Southern Switzerland IOSI Bellinzona, Switzerland |
![]() Clara Chamba, MD Muhimbili University of Health and Allied Sciences Tanzania, Africa |
![]() Peter Hillmen, MB ChB, PhD The Leeds Teaching Hospitals, St. James’s University Leeds, United Kingdom |
![]() Lydia Scarfò, MD Vita-Salute San Raffaele University Milan, Italy |
![]() Carlos Sergio Chiattone, MD, MSc, PhD Santa Casa Medical School Sao Paulo, Brazil |
![]() Arnon Kater, MD, PhD Cancer Center Amsterdam Amsterdam, Netherlands |
![]() Anna Schuh, MD, PhD, MRCP, FRCPath University of Oxford Oxford, England United Kingdom |
![]() Nicholas Chiorazzi, MD The Feinstein Institute for Medical Research Northwell Health Manhasset, New York United States |
![]() Thomas J. Kipps, MD, PhD University of California San Diego La Jolla, California United States |
![]() John Seymour, MBBS, PhD Peter MacCallum Cancer Centre Melbourne, Australia |
![]() Adalgisa Condoluci, MD Oncology Institute of Southern Switzerland Bellinzona, Switzerland |
![]() Rosa Lapalombella, PhD The Ohio State University Comprehensive Cancer Center Columbus, Ohio United States |
![]() Clare Sun, MD Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health Bethesda, Maryland United States |
![]() Florence Cymbalista, MD, PhD Avicenne Hospital Bobigny, France |
![]() David Maloney, MD, PhD Fred Hutchinson Cancer Research Center Seattle, Washington United States |
|
![]() Matthew Davids, MD, MMSc Dana-Farber Cancer Institute Boston, Massachusetts United States |
|
![]() Meghan Thompson, MD Memorial Sloan Kettering Cancer Center New York, New York United States |
![]() Peter Dreger, MD Heidelberg University Hospital Heidelberg, Germany |
![]() Javid Moslehi, MD Vanderbilt University Medical Center Nashville, Tennessee United States |
![]() William Wierda, MD, PhD The University of Texas MD Anderson Cancer Center Houston, Texas United States |
![]() Dimitar Efremov, MD, PhD International Centre for Genetic Engineering and Biotechnology Trieste, Italy |
![]() Carsten Niemann, MD, PhD Copenhagen University Hospital Copenhagen, Denmark |
|
![]() Barbara Eichhorst, MD University of Cologne Cologne, Germany |
![]() Andrea Pepper, PhD University of Sussex Brighton and Sussex Medical School Brighton, United Kingdom |
![]() ![]() Jennifer Woyach, MD The Ohio State University Comprehensive Cancer Center Columbus, Ohio United States |
|
|
![]() ![]() Catherine J. Wu, MD Dana-Farber Cancer Institute Boston, Massachusetts United States |
![]() Gianluca Gaidano, MD, PhD University of Eastern Piedmont Novara, Italy |
![]() Alan Ramsay, PhD King’s College London, United Kingdom |
|
![]() Jordan Gauthier, MD, MSc Fred Hutchinson Cancer Center Seattle, Washington United States |
![]() ![]() ![]() Tadeusz Robak, MD, PhD Medical University of Lodz Lodz, Poland |
Deborah Sims Henderson Media Group CLL Patient Advocate Victoria, Australia |
Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd Executive Vice President Chief Medical Office CLL Society Olathe, Kansas United States |
Zack Pemberton-Whiteley Chief Executive Officer Leukaemia Care Worcester, United Kingdom |
Lorna Warwick Chief Executive Officer Lymphoma Coalition Mississauga, Ontario Canada |